Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Determine the Rel Bio of AZD9833 Formulations, Food Effects and the Absolute Bioavailability of AZD9833 Following Co-Administration of an Oral Tablet Formulation With a Radiolabelled Intravenous Microdose of [14C]AZD9833

NCT04546347 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT04546347
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04546347 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Determine the Rel Bio of AZD9833 Formulations, Food Effects and the Absolute Bioavailability of AZD9833 Following Co-Administration of an Oral Tablet Formulation With a Radiolabelled Intravenous Microdose of [14C]AZD9833
Lead sponsor
AstraZeneca
Phase
Phase 1
Overall status
Completed
Start date
September 17, 2020
Completion date
January 7, 2021
Enrollment
32 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy volunteers